Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia

Mov Disord. 2013 Dec;28(14):2002-6. doi: 10.1002/mds.25720. Epub 2013 Oct 21.

Abstract

Background: Multiple studies have demonstrated decreases in striatal D2-like (D2, D3) radioligand binding in primary focal dystonias. Although most investigations have focused on D2-specific receptors (D2R), a recent study suggests that the decreased D2-like binding may be due to a D3-specific (D3R) abnormality. However, only limited data exist on the role of D1-specific receptors (D1R) and the D1R-mediated pathways within basal ganglia in dystonia. Metabolic positron emission tomography (PET) data in primary generalized dystonia suggest resting state over activity in the D1R-mediated direct pathway, leading to excessive disinhibition of motor cortical areas. This work investigated whether striatal D1-like receptors are affected in primary focal dystonias.

Methods: Striatal-specific (caudate and putamen) binding of the D1-like radioligand [(11)C]NNC 112 was measured using PET in 19 patients with primary focal dystonia (cranial, cervical, or arm) and 18 controls.

Results: No statistically significant difference was detected in striatal D1-like binding between the two groups. The study had 91% power to detect a 20% difference, indicating that false-negative results were unlikely.

Conclusions: Because [(11)C]NNC 112 has high affinity for D1-like receptors, very low affinity for D2-like receptors, and minimal sensitivity to endogenous dopamine levels, we conclude that D1-like receptor binding is not impaired in these primary focal dystonias.

Keywords: D1 receptor; [11C]NNC 112; focal dystonia; positron emission tomography.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Benzazepines / pharmacokinetics
  • Benzofurans / pharmacokinetics
  • Corpus Striatum / diagnostic imaging*
  • Corpus Striatum / metabolism*
  • Dystonic Disorders / diagnostic imaging
  • Dystonic Disorders / pathology*
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Positron-Emission Tomography
  • Receptors, Dopamine D1 / metabolism*

Substances

  • Benzazepines
  • Benzofurans
  • Receptors, Dopamine D1
  • NNC 112